Eric Deutsch, Chairman of Radiation Oncology at Institut Gustave Roussy, shared a post on LinkedIn:
“What a week in Stockholm!
Glad to see Gustave Roussy so strongly represented at ESTRO 2026, with nearly 30 contributions from our radiotherapy teams and UMR1355, dedicated to molecular radiotherapy and technological innovation.
From AI and FLASH radiotherapy to immuno-radiotherapy, lymphocyte sparing, brachytherapy and clinical trials, this was a great reminder that radiation oncology is moving fast, and that it moves best when clinicians, researchers, physicists and engineers work together.
A big bravo to all colleagues involved.
Science, teamwork and a bit of Stockholm energy: a very good mix.”
Other articles featuring Eric Deutsch on OncoDaily.
